CTLA4 and neoplasm: Starting from the success of anti-CTLA-4 antibody therapy in malignant melanoma, targeted immunotherapy has emerged as one of the most effective strategies for anti-tumor therapy, igniting a new wave of research in tumor immunotherapy [1].